WellSpan-THRIVE Cancer QOL Study
Part of paid clinical trials in Chambersburg, Pennsylvania.
- Sponsor
- WellSpan Health
- Study ID
- NCT07433660
- Status
- Recruiting
Conditions
- Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative
- Cancer (Advanced Stage)
- Cancer (Solid Tumors)
- Cancer (With or Without Metastasis)
- Cancer - Ovarian
- Cancer Abdomen
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.
Key Dates
- Start date
- Feb 28, 2026
- Status verified
- Feb 2026
- Primary completion
- Feb 28, 2031
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Patients Diagnosed with primary cancer in past 6 monthsPatients Diagnosed with primary cancer in past 6 months will be divided into Race, ethnicity and gender and will be looked for differences in quality of life based on these subsets.
Primary Outcome Measure
Quality of Life Differences based on Race or Ethnicity or Gender [ Time Frame: Baseline, 6-12-18-24 months ]
Central Contacts
- Joan K Moore, MSN, RN, OCN, CCRP717-741-8124
- Rahul Kashyap, MBBS, MBA, FCCM717-851-4611
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| WellSpan Medical Oncology & Hematology | Chambersburg | Pennsylvania | 17201 | |
| WellSpan Ephrata Cancer Center | Ephrata | Pennsylvania | 17522 | |
| WellSpan Adams Cancer Center | Gettysburg | Pennsylvania | 17325 | |
| WellSpan Sechler Family Cancer Center | Lebanon | Pennsylvania | 17042 | |
| WellSpan York Cancer Center | York | Pennsylvania | 17403 |
Find similar trials in Chambersburg, PA
Related Studies
- Survivors Uniting for Remote Guided ExerciseRecruiting · Colorado State University · Fort Collins, Colorado
- A Phase 1 Study of JMT108 in Participants With Advanced Solid TumorsPHASE1 · Recruiting · Conjupro Biotherapeutics, Inc. · Huntersville, North Carolina